Viewing Study NCT00251459


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-25 @ 1:26 PM
Study NCT ID: NCT00251459
Status: COMPLETED
Last Update Posted: 2014-03-10
First Post: 2005-11-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module